Recent Updates
Recently added Catalysts
BLTE Positive Sentiment Score: 70/100

Belite Bio to Participate in Four Upcoming Investor Conferences

Monday, May 12, 2025 1 min read
Key Takeaway: Belite Bio, Inc (NASDAQ: BLTE) has announced its participation in four upcoming investor conferences, showcasing its focus on drug development for degenerative retinal diseases. The conferences include a corporate presentation at the Deutsche Bank Depositary Receipts Virtual Investor Conference and multiple discussions at other significant events. This initiative highlights the company's commitment to engaging with investors and providing updates on their therapeutic advancements.

Market Sentiment Analysis

POSITIVE FACTORS

  • Belite Bio is participating in four significant investor conferences.
  • The company is focusing on advancing therapeutics for unmet medical needs.
  • Participation in major conferences indicates confidence in their pipeline.

Full Press Release Details

SAN DIEGO, May 12, 2025 (GLOBE NEWSWIRE) -- Belite Bio, Inc (NASDAQ: BLTE), a clinical-stage biopharmaceutical drug development company focused on advancing novel therapeutics targeting degenerative retinal diseases that have significant unmet medical needs, today announced that the executive management team will participate in four upcoming investor conferences. Details of the presentations are as follows:
Deutsche Bank Depositary Receipts Virtual Investor Conference (Virtual) May 15, 2025, at 12:30 pm ET, corporate presentation
H.C. Wainwright 3rd Annual BioConnect Investor Conference at NASDAQ (New York, NY) May 20, 2025, at 5:00 pm ET, fireside chat
Stifel 2025 Ophthalmology Forum (Virtual) May 27, 2025, at 11:00 am ET, fireside chat
Benchmark's Healthcare House Call One-on-One Conference (Virtual) May 29, 2025, at 12:45 pm ET, fireside chat
Webcast Link Instructions
A webcast of each presentation can be accessed under the "Events" tab on the investor relations section of the Belite Bio website at: https://investors.belitebio.com/presentations-events/events. The replays will be archived for 90 days following the presentation date.
Media and Investor Relations Contact:
belite@argotpartners.com

Frequently Asked Questions

What is Belite Bio, Inc. focused on?

Belite Bio, Inc. develops novel therapeutics for degenerative retinal diseases.

When is Belite Bio's investor conference presentation?

The presentation will be on May 15, 2025, at 12:30 pm ET.

Where can I watch the Belite Bio presentations?

Webcasts are available under the 'Events' tab on the Belite Bio website.

How long will the presentation replays be available?

Replays will be archived for 90 days after each presentation.

Tags: BLTE Viatris Investor Conferences Healthcare Belite Bio investor conferences retinal diseases biopharmaceutical
Last updated: May 12, 2025